Crown Crafts Announces Quarterly Cash Dividend
May 14, 2024 07:04 ET
|
Crown Crafts, Inc.
Crown Crafts Announces Quarterly Cash Dividend
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
May 14, 2024 07:00 ET
|
BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., May 14, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) today announced that new data on oral, once-daily ORLADEYO® (berotralstat) for the...
Synlogic Reports First Quarter 2024 Financial Results
May 14, 2024 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., May 14, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, today reported...
Immatics Announces First Quarter 2024 Financial Results and Business Update
May 14, 2024 07:00 ET
|
https://immatics.com/
Company Provides Clinical Data Update from Ongoing Phase 1 Clinical Trial with ACTengine® IMA203 TCR-T Targeting PRAME Updated clinical data on ACTengine® IMA203 targeting PRAME in 30 heavily...
Harvard Business School publishes Kaspi.kz case study
May 14, 2024 07:00 ET
|
JSC Kaspi.kz
ALMATY, Kazakhstan, May 14, 2024 (GLOBE NEWSWIRE) -- Joint Stock Company Kaspi.kz (“Kaspi.kz”) (Nasdaq: KSPI) announces that the company is the subject of a Harvard Business School (HBS) case study...
Bitfarms Doubles Yguazu Power Capacity to 200 MW with Additional 100 MW of Hydropower in Paraguay
May 14, 2024 07:00 ET
|
Bitfarms Ltd.
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated March 8, 2024, to its short form base shelf prospectus dated November 10, 2023. ...
Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd
May 14, 2024 07:00 ET
|
Tilray Brands, Inc.
BRECKENRIDGE BREWERY ANNOUNCES ON TAP WITH KBCO CONCERT SERIES FEATURING CANNONS, THE MOSS AND DEHD
Eyenovia to Report First Quarter 2024 Results on Wednesday, May 15th
May 14, 2024 07:00 ET
|
Eyenovia, Inc.
NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic company with two FDA-approved products and a late-stage asset in pediatric progressive myopia, today announced...
New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction
May 14, 2024 07:00 ET
|
Lexicon Pharmaceuticals, Inc.
THE WOODLANDS, Texas, May 14, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced a new post-hoc analysis of clinical data showing that INPEFA® (sotagliflozin), a...
Mural Oncology Announces First Quarter 2024 Financial Results and Provides Business Update
May 14, 2024 07:00 ET
|
Mural Oncology, Inc.
Mural Oncology reiterates cash runway projection into 4Q 2025, with sufficient capital to fund key clinical readouts.